A life saving act: SEHA highlights role of Blood Bank Services on World Blood Donor Day
SARA ALZAABI (ABU DHABI)On the occasion of World Blood Donor Day, annually marked on June 14, Abu Dhabi Health Services Company, (SEHA), the UAE's largest public healthcare network, reaffirmed the importance of voluntary blood donation and the emirate's commitment to safe transfusion protocols.Blood Bank Services, managed by SEHA with the supervision of the Department of Health – Abu Dhabi (DoH), is a nationally significant strategic initiative, adhering to international best practices to ensure the community's wellbeing.An essential part of this initiative is Abu Dhabi Blood Bank Services (ADBBS), which provides blood and blood products to health facilities throughout Abu Dhabi, Al Ain, and Al Dhafra, ensuring that safe, high-quality donations are available to meet the needs of both patients on a daily basis and emergency response.
Speaking to Aletihad , Dr. Hamad Saif Saeed Al Nuaimi, Allied Health Manager – Blood Bank Services, highlighted how SEHA is enhancing donation efforts by leveraging innovative technologies, focused outreach, and robust community involvement to address both routine and urgent transfusion requirements. 'Blood Bank Services maintains year-round blood availability through consistent donation drives, strategic planning, strong hospital coordination, and a robust donor database,' Dr. Al Nuaimi said.'Seasonal campaigns and emergency preparedness plans help meet both routine and urgent demands."On the latest technological advancements enhancing donor safety and efficiency, he highlighted the adoption of digital registration, advanced donor screening systems, and upgraded testing technologies - all of which streamline the process and uphold the highest safety standards.Reflecting on how the UAE's approach to voluntary donation has changed over the past decade, Dr. Al Nuaimi said that the UAE has transitioned towards a more community centred, education driven model.'Increased collaboration with public and private entities, digital awareness campaigns, and recognition programmes have significantly improved donor engagement and retention," he noted.To attract first-time donors, the blood bank relies on a blend of outreach strategies."Community events, mobile donation units, partnerships, and awareness campaigns linked to national days and health observances have proven effective in encouraging first time donors, especially when combined with engaging educational content," Dr. Al Nuaimi said.Regarding the management of rare blood type donations, Dr. Al Nuaimi explained that the Blood Bank maintains a dedicated registry and utilises a Frozen RBC Programme."Blood Bank Services maintains a registry of rare blood type donors and coordinates with national networks to ensure rapid response in critical cases. Donations are often frozen and stored for future use through the Frozen RBC Programme."
Youth EngagementAs a cornerstone of SEHA's long-term strategy, youth are engaged through the 'You Are the Future' programme, with the Blood Bank partnering with schools to raise awareness. "Youth engagement is vital to building a sustainable donor base. Through the 'You Are the Future' programme, Blood Bank Services partners with schools to educate students about the importance of blood donation and community service. The programme empowers youth to become future donors and ambassadors by involving them in awareness campaigns, interactive sessions, and volunteering opportunities — fostering a strong culture of giving from an early age."The service also works closely with hospitals and emergency teams to address urgent transfusion needs.He explained that Blood Bank Services is collaborating with hospitals and emergency services to meet urgent transfusion needs."Blood Bank Services works in close coordination with hospitals, trauma units, and emergency response teams to forecast needs, supply rare units quickly, and maintain a ready inventory of blood products," Dr. Al Nuaimi said."Dedicated logistics support ensures timely delivery in emergencies."To expand accessibility, particularly in remote areas, new efforts are underway."Plans include increasing mobile blood drive coverage in rural areas and outlying communities, and enhancing scheduling flexibility to facilitate appointments in underserved areas. Also, a collection site has been opened in Al Dhafra Region (Madinat Zayed) to reach the population in this area," he said.
Recognising Committed Donors"Regular donors are honoured through appreciation events, reward programmes, and national recognition initiatives like the Apheresis Hero of the Year and World Blood Donor Day. They are also kept informed through personalised messages and engaged in community stories." As a final message to the community on World Blood Donor Day, Dr. Al Nuaimi said: "Every drop counts. Today is a reminder that your selfless act can mean the difference between life and death for someone in need. By donating blood, you are not just saving lives, you're building a stronger, more compassionate community."According to data from Abu Dhabi Blood Bank Services, the number of blood donors in Abu Dhabi rose to 47,841 in 2022, marking a 41% increase compared to 2021.These donors collectively contributed 59,167 units of blood, playing a vital role in saving lives.
Furthermore, 1,006 platelet donors provided a total of 10,041 platelet units.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
2 days ago
- Al Etihad
Corniche Fertility Centre celebrates patient satisfaction, successful birth following multidisciplinary fertility care
1 July 2025 16:57 ABU DHABI (ALETIHAD)SEHA, a subsidiary of PureHealth, the largest healthcare group in the Middle East, has proudly shared the successful outcome of a complex fertility journey at Corniche Fertility Centre, part of SEHA IVF. The birth of a healthy baby girl in April 2025 stands as a testament to the centre's unwavering commitment to patient-centred care and clinical excellence, achieved through a collaborative, multidisciplinary patient, Noura, was a 39-year-old woman from Abu Dhabi suffering from secondary infertility for six years prior to her visit to the Corniche Fertility Centre. She had a history of four early miscarriages following IVF cycles and had one successful delivery prior to that in 2017. Following multiple unsuccessful treatment cycles at two additional fertility centres, Noura was referred to Corniche Fertility Centre with eight viable embryos left over from previous IVF Fertility Centre gathered a group of practitioners who used a holistic, patient-centred approach, with the aim of providing comprehensive care by communicating with its specialised Preconception Clinic (Internal Medicine) and Recurrent Miscarriage was important to ensure optimal health, given the patient's medical history of Type 2 Diabetes and previous pregnancy losses, during a round of full assessment to help reduce the risk of further August 2024, one embryo was ultimately transferred after appropriate medical preparation had been was confirmed by ultrasound at the end of August, and on April 8, 2025, the patient delivered a healthy baby girl - her first successful delivery after IVF and IVF Specialist at Corniche Hospital, Dr. Raquel Loja Vitorino, said, 'This was a particularly complex case due to the patient's history of pregnancy loss even after transferring genetically viable embryos.' 'The successful delivery after the first treatment cycle at our centre reflects the strength of our integrated approach and the exceptional quality of care we provide.'
Gulf Today
23-06-2025
- Gulf Today
Abu Dhabi hosts 2-day oncology conference
The third edition of the Best of ASCO UAE Conference opened on Saturday in Abu Dhabi. Organised by SEHA, part of the PureHealth Group, in collaboration with Tawam Hospital, the event is taking place at Dusit Thani Hotel and continues until Sunday June 23, bringing together a distinguished line-up of oncology experts from around the world. Held under licence from the American Society of Clinical Oncology (ASCO), the conference features more than 70 international, regional and local speakers, including oncology leaders from across the Gulf Cooperation Council and the UAE. The programme includes over 70 scientific papers that have significantly influenced oncology treatment strategies this year. Professor Julie Gralow, Chief Medical Officer and Executive Vice President of ASCO, told the Emirates News Agency (WAM) that the annual ASCO meeting highlighted key developments, including the use of circulating tumour DNA for diagnosis and the role of artificial intelligence in supporting pathologists with more accurate tumour assessments. Gralow emphasised the importance of healthy lifestyle habits in improving patient outcomes, citing a recent randomised study that found regular exercise following a colon cancer diagnosis led to reduced recurrence and mortality rates. She underscored the benefits of combining physical activity with a balanced diet and weight loss to enhance treatment effectiveness. She also highlighted rapid advances in immunotherapy, particularly in antibody-drug conjugates and immune checkpoint inhibitors, which are now being used in new therapeutic indications and earlier stages of cancer. On the subject of precision medicine, Gralow explained that the approach aims to identify molecular mutations that transform cells into cancerous forms and to develop treatments that precisely target those mutations. Many such targeted therapies have demonstrated efficacy in treating abnormal cancer-causing cells. Dr. Khalid Saeed Balaraj, Chair of the Oncology Centre at Tawam Hospital, and Vice-Chair of the Conference, said the event includes more than seven specialist scientific workshops designed for junior doctors. These sessions aim to equip them for future roles in cancer care and provide valuable opportunities for direct engagement with leading international oncology researchers. WAM
Al Etihad
21-06-2025
- Al Etihad
Best of ASCO UAE Conference opens in Abu Dhabi with focus on oncology
21 June 2025 15:53 ABU DHABI (WAM)The third edition of the Best of ASCO UAE Conference opened Saturday in Abu by SEHA, part of the PureHealth Group, in collaboration with Tawam Hospital, the event is taking place at Dusit Thani Hotel and continues until Sunday, bringing together a distinguished line-up of oncology experts from around the under licence from the American Society of Clinical Oncology (ASCO), the conference features more than 70 international, regional and local speakers, including oncology leaders from across the Gulf Cooperation Council and the programme includes over 70 scientific papers that have significantly influenced oncology treatment strategies this Julie Gralow, Chief Medical Officer and Executive Vice President of ASCO, told the Emirates News Agency (WAM) that the annual ASCO meeting highlighted key developments, including the use of circulating tumour DNA for diagnosis and the role of artificial intelligence in supporting pathologists with more accurate tumour emphasised the importance of healthy lifestyle habits in improving patient outcomes, citing a recent randomised study that found regular exercise following a colon cancer diagnosis led to reduced recurrence and mortality rates. She underscored the benefits of combining physical activity with a balanced diet and weight loss to enhance treatment also highlighted rapid advances in immunotherapy, particularly in antibody-drug conjugates and immune checkpoint inhibitors, which are now being used in new therapeutic indications and earlier stages of the subject of precision medicine, Gralow explained that the approach aims to identify molecular mutations that transform cells into cancerous forms and to develop treatments that precisely target those mutations. Many such targeted therapies have demonstrated efficacy in treating abnormal cancer-causing Khalid Saeed Balaraj, Chair of the Oncology Centre at Tawam Hospital, and Vice-Chair of the Conference, said the event includes more than seven specialist scientific workshops designed for junior doctors. These sessions aim to equip them for future roles in cancer care and provide valuable opportunities for direct engagement with leading international oncology discussed the emergence of new drugs that have proven effective against various cancers, noting that the conference will explore the potential for incorporating these treatments into formal care protocols, with particular emphasis on advances in treating breast cancer in also pointed to the breakthrough progress in immunotherapies and targeted therapies, which accurately attack tumours while preserving healthy surrounding added that modern medical care is increasingly based on developing individualised treatment plans tailored to each patient's unique biological and molecular profile. This approach can result in different treatment strategies for two patients with the same diagnosis, depending on their respective responses to treatment. He noted that ASCO organises an annual international conference attended by leading oncology scientists and researchers from around the world. Mouza Al Amri, Consultant Breast Surgeon and Acting Director of Breast Cancer Care Centre at Tawam Hospital, announced during the conference the launch of the Emirates Society of Radiation Oncology (ESRO). Based in Abu Dhabi, the society will focus on patient care, continuing medical education in oncology, radiation therapy and cancer surgery. She confirmed that the society's operations officially commenced on Saturday.
